Catalog Number 1CX*FX15W |
Device Problem
Coagulation in Device or Device Ingredient (1096)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 10/01/2015 |
Event Type
malfunction
|
Manufacturer Narrative
|
The actual device has not been returned to the manufacturing facility for evaluation.A follow up will be sent within 30 days of this report being sent.A review of the device history record and the product released decision control sheet of the involved product/lot number combination was conducted with no relevant findings.A review of the complaint history files confirmed that the involved product/lot number combination has been reported previously.See mdr# 9681834-2015-00229.(b)(4).All available information has been placed on file in quality assurance for appropriate tracking, trending and follow-up.(b)(4).Actual device not returned.
|
|
Event Description
|
The user facility reported thrombus in the capiox cx*fx15w device.Follow up communication with the user facility reported the following information: white substance was found on the fiber bundle and outside of the filter media during cardiopulmonary bypass.The product was not changed out.The surgery was completed successfully.No known impact to the patient.This product was the replacement oxygenator reported in mdr# 9681834-2015-00229.
|
|
Manufacturer Narrative
|
As stated this report is being submitted as follow-up no.1 for mfg.Report no.(b)(6) to provide the returned sample evaluation results.(b)(4).The actual device and a photo were returned to the manufacturing facility for evaluation.Visual inspection upon receipt revealed no defects.The actual sample was rinsed and dried and subjected to another visual inspection.No anomalies or defects were revealed.The actual sample was built into a circuit with tubes and bovine blood was circulated through it at each flow rate, while the pressure drop was determined and confirmed to meet manufacturing specifications.The actual sample was disassembled and the state of the x-coat applied to the inside surface of the housing confirmed no anomalies or defects.The photo of the actual device under actual use revealed the presence of white thrombus formed inside the oxygenator module.The perfusion record was reviewed as follows: b)(6).The cause for the reported event cannot be definitively determined based upon the available information since the investigation results verified that the actual sample was the normal product.There are many complex clinical variables that may have affected the reportedly observed conditions during the procedure, however there is no evidence that the reported event was related to a product malfunction or defect.The device labeling (ifu) does address instructions with statements such as the following: (1) adequate heparinization of the blood is required to prevent it from clotting in the system.All available information has been placed on file in quality assurance for appropriate tracking, trending and follow-up.
|
|
Event Description
|
This report is being submitted as follow-up no.1 for mfg.Report no.(b)(6) to provide the returned sample evaluation results.
|
|
Search Alerts/Recalls
|